Uterine Sarcoma

+ -Text Size

Early Detection, Diagnosis, and Staging TOPICS

Survival rates for uterine sarcoma by stage

Survival rates are often used by doctors as a standard way of discussing a person's prognosis (outlook). Some patients with cancer may want to know the survival statistics for people in similar situations, while others may not find the numbers helpful, or may even not want to know them. If you decide that you do not want to know about the survival rates for uterine sarcoma given in the next few paragraphs, skip to the next section.

The 5-year survival rate refers to the percentage of patients who live at least 5 years after their cancer is diagnosed. Of course, many people live much longer than 5 years (and many are cured).

Five-year relative survival rates compare the survival of people with the cancer to the survival for people without the cancer. This is a way to take into account deaths from causes other than cancer. The 5-year relative survival rate is a better way to describe the impact of a particular type and stage of cancer on survival.

In order to get 5-year survival rates, doctors have to look at people who were treated at least 5 years ago. Improvements in treatment since then may result in a more favorable outlook for people now being diagnosed with uterine sarcoma.

Survival rates are often based on previous outcomes of large numbers of people who had the disease, but they cannot predict what will happen in any particular person's case. Many other factors may affect a person's outlook, such as their general health and how well their cancer responds to treatment. Your doctor can tell you how the numbers below may apply to you, as he or she is familiar with the aspects of your particular situation.

The outlook for survival (prognosis) for women with a uterine sarcoma depends on many factors. These include

  • The stage of the cancer
  • The type of sarcoma (leiomyosarcoma or endometrial stromal sarcoma)
  • The grade of the sarcoma (low grade versus high grade)
  • The woman's general state of health
  • The treatment received

The survival statistics noted below come from the National Cancer Institute's SEER program. They are based on women diagnosed with uterine sarcomas from 1988 to 2001. The stages listed reflect the staging system that was in place at the time -- staging has changed since then. What was then stage II would now be included with stage I. Many of the cancers that were stage III in the older system would now be classified as stage II. Some of the cancers that were stage IV in the older system would now be stage III. These differences in staging may make it more difficult to apply these numbers to your own situation.

The 5-year relative survival rates for leiomyosarcoma are:

    Stage I

    60%

    Stage II

    35%

    Stage III

    28%

    Stage IV

    15%

The 5-year relative survival rates for endometrial stromal sarcoma are:

    Stage I

    90%

    Stage II

    40% *

    Stage III

    64%

    Stage IV

    37%

*Note: there were only a small number in this group so this estimate may not be accurate


Last Medical Review: 01/22/2013
Last Revised: 02/12/2014